Work

Abstract B012: Anti-tumor activity of the METAP2 inhibitor evexomostat (SDX-7320) in multiple stage-specific models of prostate cancer, including treatment refractory and neuroendocrine (AVPC) phenotypes

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.prostateca26-b012

Authors: Peter Cornelius, Devina Laurencia, Jennifer H. Gunter, Anja Rockstroh, Benjamin A. Mayes, Pierre Dufour, Bradley J. Carver, James M. Shanahan, Colleen Nelson

Institutions: SynDevRx (United States), Queensland University of Technology

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7124884071

Cites:

Cited by:

Related to: